LPL Financial’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-19,844
Closed -$531K 5971
2025
Q4
$531K Buy
19,844
+5,199
+36% +$134K ﹤0.01% 4649
2025
Q3
$390K Buy
+14,645
New +$378K ﹤0.01% 4839
2025
Q2
Sell
-14,300
Closed -$415K 5558
2025
Q1
$415K Sell
14,300
-6,066
-30% -$194K ﹤0.01% 4336
2024
Q4
$756K Buy
20,366
+1,510
+8% +$69K ﹤0.01% 3729
2024
Q3
$915K Buy
18,856
+12,104
+179% +$531K ﹤0.01% 3476
2024
Q2
$270K Buy
+6,752
New +$280K ﹤0.01% 4358
2024
Q1
Sell
-23,231
Closed -$1.44M 4916
2023
Q4
$1.44M Buy
23,231
+2,603
+13% +$137K ﹤0.01% 2712
2023
Q3
$949K Buy
20,628
+7,371
+56% +$402K ﹤0.01% 2946
2023
Q2
$762K Buy
13,257
+44
+0.3% +$1.95K ﹤0.01% 3088
2023
Q1
$495K Buy
+13,213
New +$433K ﹤0.01% 3340
2022
Q2
Sell
-59,466
Closed -$2.13M 4420
2022
Q1
$2.13M Buy
+59,466
New +$1.69M ﹤0.01% 2020
2019
Q3
Sell
-14,773
Closed -$312K 3292
2019
Q2
$312K Buy
+14,773
New +$309K ﹤0.01% 2670

Other funds holding AMPH

LPL Financial's AMPH Position: Q1 2026 in Review

LPL Financial sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2026, closing a stake of 19,844 shares — an estimated $531K sold.

LPL Financial first reported a position in AMPH in Q2 2019 and held it in 12 quarters. The position peaked at $2.13M in Q1 2022. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • LPL Financial reported no remaining Amphastar Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • LPL Financial sold 19,844 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $531K.
  • LPL Financial first reported a position in Amphastar Pharmaceuticals in Q2 2019 and held it in 12 quarters.
  • LPL Financial's Amphastar Pharmaceuticals position peaked at $2.13M in Q1 2022.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.